Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse... GlobeNewswire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on SER
    SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AGE, GRPH, FIXX
    8:52p ET February 27 '24 PR Newswire

    Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

    https://mma.prnewswire.com/media/2275069/Halper_Sadeh_LLP_Logo.jpg

    AgeX Therapeutics, Inc. (NYSE: AGE)'smerger with Serina Therapeutics, Inc. Upon completion of the merger, pre-merger AgeX stockholders are expected to own approximately 25% of the newly combined company.If you are an AgeX shareholder, click here to learn more about your rights and options.

    Graphite Bio, Inc. (NASDAQ: GRPH)'smerger with LENZ Therapeutics. Graphite shareholders are expected to own approximately 35% of the combined company upon the closing of the merger. If you are a Graphite shareholder, click here to learn more about your rights and options.

    Homology Medicines, Inc. (NASDAQ: FIXX)'smerger withQ32 Bio Inc. Upon completion of the proposed transaction, Homology shareholders are expected to own approximately 25% of the combined company. If you are a Homology shareholder, click here to learn more about your rights and options.

    Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

    Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.comor zhalper@halpersadeh.com.

    Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

    Attorney Advertising. Prior results do not guarantee a similar outcome.

    Contact Information:Halper Sadeh LLCDaniel Sadeh, Esq.Zachary Halper, Esq.(212) 763-0060sadeh@halpersadeh.comzhalper@halpersadeh.com https://www.halpersadeh.com

    https://c212.net/c/img/favicon.png?sn=NY47512&sd=2024-02-27

    View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-update-halper-sadeh-llc-investigates-age-grph-fixx-302073464.html

    SOURCE Halper Sadeh LLP

    https://rt.newswire.ca/rt.gif?NewsItemId=NY47512&Transmission_Id=202402272052PR_NEWS_USPR_____NY47512&DateId=20240227

    COMTEX_448452408/1005/2024-02-27T20:52:24

    Serina Therapeutics Reports First Quarter 2024 Financial Results and ...
    4:05p ET May 14 '24 GlobeNewswire
    Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
    4:05p ET April 17 '24 GlobeNewswire
    AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Re...
    5:27p ET March 22 '24 GlobeNewswire
    SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates AGE, GRPH, FIXX
    8:52p ET February 27 '24 PR Newswire

    Market data provided by News provided by